Dr. Sascha Berger
Global Investor | Strategic Advisor
Founded by Dr Sascha Berger, Berger Invest partners with emerging and growth-stage companies as a strategic advisor and early investor: bridging global innovation with global capital and opportunity.⸻💡 AdvisoryStrategic Advisory for Biotech & DeepTech CompaniesI work directly with founders and boards to help navigate critical inflection points in financing, strategy, and international expansion.How I add value :
• Fundraising and investor interaction strategy
• Commercial and market entry planning
• Executive and board-level mentorshipExample : Senior Advisor to a European Series A neuro platform company (2025 – 2026)⸻🌍 Ecosystem / Middle East BridgeConnecting Global Opportunity with Global CapitalBased in the Middle East, I support sovereign wealth funds and family offices in building healthcare and deep-tech (biotech, medtech, AI) exposure and evaluating opportunities.Activities include :
• Advisory on fund formation and investment strategy
• Opportunity evaluation and selection
• Private briefings and workshops for family offices
• Facilitating cross-regional partnerships (Europe / Gulf / North America)⸻💶 InvestmentsAngel and Co-Investment PlatformBerger Invest is also my personal vehicle for selective early-stage and fund investments in life sciences and deep-tech.Focus :
• Transformational Biotech platform technologies
• Disruptive and commercially attractive Medtech opportunities
• Defendable and Unique AI and Digital Health technologies
• LP positions and co-investments alongside global VC and sovereign wealth partners.⸻👤 AboutDr. Sascha Berger is an investment executive, board member, and strategic advisor with nearly two decades at the intersection of science, finance, and innovation.A former General Partner at TVM Capital, he led more than $100 million in biotech and medtech investments across the US and Europe, including multiple successful exits and a NASDAQ IPO. Today, as Investment Director at NEOM - part of Saudi Arabia’s Public Investment Fund ecosystem - he builds NEOM’s global biotech and AI investment platform and helps shape the Kingdom’s next-generation life-science ecosystem.Dr. Berger began his career with BCG, PwC, Deutsche Bank, and one of Germany’s largest family offices, gaining a foundation in strategy, M&A, and asset management. He has supported the structuring of cross-border funds exceeding $500 million, served on numerous boards, and advised founders and investors on scaling breakthrough technologies.Educated at leading academic institutions including Munich University or Technology, the National University of Singapore, and MIT, he holds a PhD in Finance and a training in (bio-) chemistry - a rare combination that enables him to bridge scientific insight with investment strategy.An active angel investor, mentor, and industry voice, Dr. Berger contributes regularly for many years at global forums such as BIO International, the Jefferies and JPM Healthcare Conferences, and the LSX CEO Congress. He also serves on the Executive Board of the Life Sciences Acceleration Alliance (LSAA).Culturally fluent between East and West, he lives in the Middle East, travels extensively across global innovation hubs, and continues to connect capital, science, and visionary leadership worldwide.Today I apply that experience through Berger Invest to help innovators and investors alike.⸻✉️ ContactLet’s explore working together.Connect via email or LinkedIn